NYSE$AMPX
Amprius Technologies Inc · Q4 2024 earnings
Q4 2024 earnings · · After market close · Investor relations
Briefing
AMPX reported Q4 2024 revenue of $10.6M, a net loss of $11.4M, diluted EPS of $-0.10.
For Q4 2024, AMPX reported Revenue was $10.6M, net loss was $11.4M, diluted EPS was $-0.10. Management discusses segment trends, liquidity, and outlook in the quarterly filing.
- Revenue $10.6M for Q4 2024.
- Net loss $11.4M.
- Diluted EPS $-0.10.
Headline financials
Revenue & EPS history
Amprius · Revenue · Quarterly
$10.6M
Forward guidance
Outlook emphasizes clinical milestones, liquidity runway, and operating expense discipline.
Tailwinds
- Pipeline progress and partnership economics.
- Cash supports near-term operating plans.
Headwinds
- Operating losses until commercial scale.
- Financing and trial outcomes affect funding costs.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 15 quarterly earnings reports · overlaid with Q4 2024
+6.2%
Avg return
Earnings day
+9.5%
Avg return
5 days after
-0.7%
Avg return
30 days after
53%
8 / 15 earnings
Positive
+37.3%
Q3 2024
Best reaction
-27.4%
Q1 2026
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -27.4% | -15.2% | -11.6% | |
| Q4 2025 | +18.6% | +43.4% | +27.5% | |
| Q3 2025 | +12.4% | +9.9% | +8.2% | |
| Q1 2025 | -1.2% | +13.7% | +16.5% | |
| Q4 2024 | +34.6% | +32.5% | -7.4% | |
| Q3 2024 | +37.3% | +99.2% | +62.7% | |
| Q2 2024 | +2.8% | +0.0% | -32.7% | |
| Q1 2024 | -8.8% | -39.8% | -37.0% | |
| Q4 2023 | -5.2% | -12.0% | -39.5% | |
| Q3 2023 | +4.2% | +5.5% | +32.1% | |
| Q2 2023 | -10.4% | -11.7% | -48.4% | |
| Q1 2023 | -1.7% | -2.6% | +6.7% | |
| Q4 2022 | +36.4% | +25.8% | +72.7% | |
| Q3 2021 | -8.5% | -6.2% | -34.2% | |
| Q3 2022 | +9.3% | +0.0% | -26.2% | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — | |
| Q4 2021 | — | — | — | |
| Q2 2021 | — | — | — | |
| Q1 2021 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro